EMAN RESEARCH PUBLISHING | Journal | About Journal
Angiogenesis biology and therapeutics

About the Journal

The Journal of Angiotherapy is an international, peer-reviewed, Open Access journal that publishes research articles on all aspects of angiogenesis. Multi-disciplinary, fully peer-reviewed, both non-open and open access, international scholarly journal. It will publish the article 1) describe significant and novel findings; and 2) advance knowledge in a diversity of scientific fields. These fields include all aspect of:  Angiogenesis based translational research with special focus on botanical extracts and botanical derived therapeutics with preclinical and clinical trial, strict criteria will be on standardized extract with full characterization of active biomarkers. New findings on Cancer therapy and biomarkers are also welcomed. The Journal also welcomes submission of manuscripts from cross-disciplinary fields, including Pharmaceutical Sciences, Biochemistry & Structural Biology, Biotechnology, Bioinformatics & Computational Biology, Cell, Molecular & Developmental Biology, Medicine, Evolutionary Biology & Molecular Ecology, Genetics & Genomics, Immunology, Microbiology, Parasitology & Virology, Neuroscience, Plant Sciences, Chemical Sciences, and Zoology.

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict double blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The general criteria for acceptance of a manuscript are:

  • advances Angiogenesis and herbal therapeutics based scientific knowledge;

  • advances translational research;

  • provides an adequate and relevant literature review;

  • utilizes scientifically solid, reliable, and reproducible methodologies;

  • derives appropriate and justifiable conclusions based upon the experimental data presented; and

  • is written in English and is of the utmost quality and clarity.

Angiotherapy is dedicated to the dissemination of fundamental information related to the clinical and pre-clinical research on natural products, plant extract, small molecules in angiogenesis and angiogenesis dependent disease including cancer, arthritis and obesity. Full-length articles presenting the results of original research, Review, Data report and brief communications are featured. The Journal publish article continuously. All accepted manuscripts are granted free online open-access immediately after publication, which permits its users to read, download, copy, distribute, print, search, or link to the full texts of its articles, thus facilitating access to a broad readership.

Angiotherapy facilitates the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.

Journal Officials Editor-in-Chief, Executive Editor, Assistant Editors, Section Editors, and Production Editors.

Publisher
EMAN Research

ISSN

 print :2207-8843; online:2207-872X. National Library of Australia 

Frequency Continuous

Ranking: Angiotherapy

Research Angiogenesis related areas include:

  • Biochemistry 

  • Bioengineering 

  • Biomathematics 

  • Biophysics 

  • Cancer 

  • Comparative physiology 

  • Drug delivery 

  • Neuropharmacology 

  • Pathology 

Angiotherapy facilitates the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.

Indexing

CrossRef, Publons, Google Scholar, Researchgate, Trove (National LIbrary of Australia).

Submitted for indexing CABI, EBSCOhost.

Committee on Publication Ethics


Submit Article

Use the online submission system to send us your manuscript.


Call for Papers

We are seeking Contributions for a special issue.  More.


Best Paper Award

Authors are awarded for Best Paper for this Journal Annually


Advertisement

Journal of Angiotherapy